米国の治験用包装市場規模、シェア、動向分析レポート：素材別、製品別、最終用途別、セグメント予測、主要企業、競合分析、2025年～2030年

米国の治験用包装市場のサマリー

米国の治験用包装市場規模は、2024年に9億1,590万米ドルと推計され、2030年には16億1,140万米ドルに達し、2025年から2030年までのCAGRは9.9%で成長すると予測されています。成長の原動力は、特に生物製剤や遺伝子治療を含む新薬や治療法の臨床試験件数の増加です。

慢性疾患の増加により、製薬・バイオテクノロジー分野では継続的な研究開発が必要となり、試験段階を通じて医薬品の安定性、安全性、完全性を確保するための特殊な包装ソリューションに対する需要が高まっています。規制当局の監視が強化され、試験プロトコルが複雑化しているため、安全で適応性の高い包装形態が必要とされています。米国の治験用包装業界の成長は、製薬研究開発への投資の増加や新薬開発の急増が拍車をかけ、臨床試験件数が増加していることが主な要因となっています。

イノベーションは米国の治験用包装業界の要であり、医薬品の安定性向上、患者のコンプライアンス、サプライチェーンの効率化といったニーズが継続的に後押ししています。企業はRFIDや温度監視装置などのスマートパッケージング技術に投資し、製品状態のリアルタイムデータを提供し、コールドチェーンロジスティクス全体を通じて完全性を確保しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の治験用包装市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連市場見通し
• 業界バリューチェーン分析
• 規制の枠組み
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 業界の課題
  • 業界の機会
• 業界分析ツール
  • ポーターのファイブフォース分析
  • マクロ環境分析

第4章 米国の治験用包装市場：素材推定・動向分析

• セグメントダッシュボード
• 米国の治験用包装市場：素材変動分析と市場シェア、2024年と2030年
• プラスチック
• ガラス
• 金属
• 紙と段ボール

第5章 米国の治験用包装市場：製品推定・動向分析

• セグメントダッシュボード
• 米国の治験用包装市場：製品変動分析と市場シェア、2024年と2030年
• 注射器
• バイアルとアンプル
• ボトル
• バッグ＆ポーチ

第6章 米国の治験用包装市場：最終用途の推定・動向分析

• セグメントダッシュボード
• 米国臨床試験用パッケージ市場：最終用途変動分析と市場シェア、2024年および2030年
• 調査室
• 臨床研究機関
• 医薬品製造施設

第7章 米国の治験用包装市場-競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業分類
• 企業ヒートマップ
• ポジション分析、2024年
• 戦略マッピング
  • 拡大
  • 合併と買収
  • パートナーシップとコラボレーション
  • 新しいフィルムタイプの発売
  • 研究開発
• 企業プロファイル
  • Catalent, Inc.
  • PCI Pharma Services
  • Parexel International（MA）Corporation
  • Piramal Pharma Limited
  • Rubicon Research Limited
  • Schreiner Group
  • Sharp Services, LLC

List of Tables

• Table 1 List of Abbreviations
• Table 2 U.S. Clinical Trial Packaging Market, 2018 - 2030 (USD Million)
• Table 3 U.S. Clinical Trial Packaging Market Estimates and Forecasts by Material, 2018 - 2030 (USD Million)
• Table 4 U.S. Clinical Trial Packaging Market Estimates and Forecasts by Product, 2018 - 2030 (USD Million)
• Table 5 U.S. Clinical Trial Packaging Market Estimates and Forecasts by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market Research Process
• Fig. 2 Data Triangulation Techniques
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 QFD Modeling for Market Share Assessment
• Fig. 6 Information Procurement
• Fig. 7 Market Formulation and Validation
• Fig. 8 Data Validating & Publishing
• Fig. 9 Market Segmentation & Scope
• Fig. 10 U.S Clinical Trial Packaging Market Snapshot
• Fig. 11 Segment Snapshot (1/2)
• Fig. 12 Segment Snapshot (1/2)
• Fig. 13 Competitive Landscape Snapshot
• Fig. 14 Parent Market Outlook
• Fig. 15 U.S Clinical Trial Packaging Market Value, 2024 (USD Million)
• Fig. 16 U.S Clinical Trial Packaging Market - Value Chain Analysis
• Fig. 17 U.S Clinical Trial Packaging Market - Market Dynamics
• Fig. 18 U.S Clinical Trial Packaging Market - PORTER's Analysis
• Fig. 19 U.S Clinical Trial Packaging Market - PESTEL Analysis
• Fig. 20 U.S Clinical Trial Packaging Market Estimates & Forecasts, By Material: Key Takeaways
• Fig. 21 U.S Clinical Trial Packaging, By Material Type, 2024 & 2030
• Fig. 22 Plastic Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Glass Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Metal Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Paper & Corrugated Fiber Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 26 U.S Clinical Trial Packaging Market Estimates & Forecasts, By Product: Key Takeaways
• Fig. 27 U.S Clinical Trial Packaging Market Share, By Product Type, 2024 & 2030
• Fig. 28 Syringes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Vials & Ampoules Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Bottles Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Bags & Pouches Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 32 U.S Clinical Trial Packaging Market Estimates & Forecasts, By End Use: Key Takeaways
• Fig. 33 U.S Clinical Trial Packaging Market Share, By End Use, 2024 & 2030
• Fig. 34 Research Laboratories Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Clinical Research Organizations Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Drug Manufacturing Facilities Market Estimates & Forecasts, 2018 - 2030 (USD Million)

U.S. Clinical Trial Packaging Market Summary

The U.S. clinical trial packaging market size was estimated at USD 915.9 million in 2024 and is projected to reach USD 1,611.4 million by 2030, growing at a CAGR of 9.9% from 2025 to 2030. The growth is driven by the increasing number of clinical trials, particularly for novel drugs and therapies, including biologics and gene therapies.

The rising prevalence of chronic diseases necessitates continuous research and development in the pharmaceutical and biotechnology sectors, leading to a higher demand for specialized packaging solutions to ensure drug stability, safety, and integrity throughout the trial phases. Increasing regulatory scrutiny and the complexity of trial protocols necessitate secure and adaptive packaging formats. The growth of the U.S. clinical trial packaging industry is primarily driven by the rising number of clinical trials, spurred by growing investments in pharmaceutical R&D and the surge in novel drug development.

Innovation is a cornerstone of the U.S. clinical trial packaging industry, continuously driven by the need for enhanced drug stability, patient compliance, and supply chain efficiency. Companies invest in smart packaging technologies, such as RFID and temperature monitoring devices, to provide real-time data on product conditions and ensure integrity throughout cold chain logistics.

U.S. Clinical Trial Packaging Market Report Segmentation

This report forecasts revenue growth at U.S. level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. clinical trial packaging industry report based on material, product, and end use:

• By Material Outlook (Revenue, USD Million, 2018 - 2030)
• Plastic
• Glass
• Metal
• Paper & Corrugated Fiber
• By Product Outlook (Revenue, USD Million, 2018 - 2030)
• Syringes
• Vials & Ampoules
• Bottles
• Bags & Pouches
• Others
• By End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Research Laboratories
• Clinical Research Organizations
• Drug Manufacturing Facilities

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Raw Materials & Third-Party Perspectives
  • 1.3.4. Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
• 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Clinical Trial Packaging Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related Market Outlook
• 3.2. Industry Value Chain Analysis
• 3.3. Regulatory Framework
• 3.4. Market Dynamics
  • 3.4.1. Market Driver Analysis
  • 3.4.2. Market Restraint Analysis
  • 3.4.3. Industry Challenges
  • 3.4.4. Industry Opportunities
• 3.5. Industry Analysis Tools
  • 3.5.1. Porter's Five Forces Analysis
  • 3.5.2. Macro-environmental Analysis

Chapter 4. U.S. Clinical Trial Packaging Market: Material Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Clinical Trial Packaging Market: Material Movement Analysis & Market Share, 2024 & 2030
• 4.3. Plastic
  • 4.3.1. Plastic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Glass
  • 4.4.1. Glass Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Metal
  • 4.5.1. Metal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Paper & Corrugated Fiber
  • 4.6.1. Paper & Corrugated Fiber Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Clinical Trial Packaging Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Clinical Trial Packaging Market: Product Movement Analysis & Market Share, 2024 & 2030
• 5.3. Syringes
  • 5.3.1. Syringes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Vials & Ampoules
  • 5.4.1. Vials & Ampoules Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Bottles
  • 5.5.1. Bottles Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Bags & Pouches
  • 5.6.1. Bags & Pouches Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Clinical Trial Packaging Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Clinical Trial Packaging Market: End Use Movement Analysis & Market Share, 2024 & 2030
• 6.3. Research Laboratories
  • 6.3.1. Research Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Clinical Research Organizations
  • 6.4.1. Clinical Research Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Drug Manufacturing Facilities
  • 6.5.1. Drug Manufacturing Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Clinical Trial Packaging Market - Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map
• 7.4. Position Analysis, 2024
• 7.5. Strategy Mapping
  • 7.5.1. Expansion
  • 7.5.2. Mergers & Acquisition
  • 7.5.3. Partnerships & Collaborations
  • 7.5.4. New Film Type Launches
  • 7.5.5. Research And Development
• 7.6. Company Profiles
  • 7.6.1. Catalent, Inc.
    • 7.6.1.1. Participant's overview
    • 7.6.1.2. Financial performance
    • 7.6.1.3. Product benchmarking
    • 7.6.1.4. Recent developments
  • 7.6.2. PCI Pharma Services
    • 7.6.2.1. Participant's overview
    • 7.6.2.2. Financial performance
    • 7.6.2.3. Product benchmarking
    • 7.6.2.4. Recent developments
  • 7.6.3. Parexel International (MA) Corporation
    • 7.6.3.1. Participant's overview
    • 7.6.3.2. Financial performance
    • 7.6.3.3. Product benchmarking
    • 7.6.3.4. Recent developments
  • 7.6.4. Piramal Pharma Limited
    • 7.6.4.1. Participant's overview
    • 7.6.4.2. Financial performance
    • 7.6.4.3. Product benchmarking
    • 7.6.4.4. Recent developments
  • 7.6.5. Rubicon Research Limited
    • 7.6.5.1. Participant's overview
    • 7.6.5.2. Financial performance
    • 7.6.5.3. Product benchmarking
    • 7.6.5.4. Recent developments
  • 7.6.6. Schreiner Group
    • 7.6.6.1. Participant's overview
    • 7.6.6.2. Financial performance
    • 7.6.6.3. Product benchmarking
    • 7.6.6.4. Recent developments
  • 7.6.7. Sharp Services, LLC
    • 7.6.7.1. Participant's overview
    • 7.6.7.2. Financial performance
    • 7.6.7.3. Product benchmarking
    • 7.6.7.4. Recent developments